JAZZ — Jazz Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual balance sheet for Jazz Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	591	881	1,626	2,993	2,442
Net Total Accounts Receivable
Net Total Receivables	563	743	855	717	831
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,611	2,606	3,435	4,629	4,166
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	343	301	235	227	259
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	12,299	10,835	11,393	12,012	11,659
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	809	933	1,537	1,039	2,243
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	8,333	7,750	7,656	7,919	7,341
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3,965	3,086	3,737	4,094	4,319
Total Liabilities & Shareholders' Equity	12,299	10,835	11,393	12,012	11,659
Total Common Shares Outstanding